Methylphenidate Transdermal System Patch
Product Images NDC 0574-2420

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Methylphenidate Transdermal System (NDC 0574-2420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg (10mg)

Packaging label for Methylphenidate Transdermal System, a patch delivering 10 mg over 9 hours (1.1 mg/hr). The label shows the product name, route as transdermal, and contains 30 patches. It is Rx only and manufactured by Padagis US LLC. The label includes directions that the patch should be worn for approximately 9 hours, with detailed application and removal log tables visible on the inside panel.*

FDA Label Image

15mg (15mg)

Packaging label for Methylphenidate Transdermal System patch, delivering 15 mg over 9 hours (1.6 mg/hr). The label shows a 30-patch supply and highlights the transdermal route and 9-hour wear time. The product is manufactured by Padagis US LLC and is prescription only. The label includes usage instructions and a barcode on the package.*

FDA Label Image

20mg (20mg)

Packaging label for Methylphenidate Transdermal System patch by Padagis US LLC. The label describes a patch delivering 20 mg over 9 hours (2.2 mg/hr), with 30 patches per container. It includes dosage and application instructions, storage warnings, and the NDC number 0574-2420-65. The label specifies the patch should be worn for approximately 9 hours.*

FDA Label Image

30mg (30mg)

Packaging label for Methylphenidate Transdermal System patch, delivered by Padagis US LLC. The label states that each patch delivers 30 mg of methylphenidate over 9 hours (3.3 mg/hr). The package contains 30 patches and is marked for prescription use only. The label also includes dosing instructions for approximately 9 hours of wear and a table for recording patch application details.*

FDA Label Image

Circle (Circle)

Packaging label of Methylphenidate Transdermal System patches from PADAGIS US LLC. The label shows four available strengths: 27.5 mg, 41.3 mg, 55 mg, and 82.5 mg. The product is a human prescription drug in transdermal patch form, used for systemic delivery of methylphenidate.*

FDA Label Image

Figure1 (Figure1)

A line graph showing d-Methylphenidate concentration (ng/mL) over time (hours) following application of the Methylphenidate Transdermal System. The x-axis represents time after application up to 30 hours, and the y-axis shows concentration levels up to 30 ng/mL. Multiple curves illustrate concentration changes over time, peaking around 8 to 10 hours and declining thereafter.*

FDA Label Image

Figurea (Figurea)

An illustration showing application of a Methylphenidate Transdermal System patch on the hip or lower abdomen. The image depicts a hand holding the patch against skin, partially lifting clothing to expose the application site.*

FDA Label Image

Figureb (Figureb)

An instructional line drawing showing hands cutting a rectangular patch with scissors. The image depicts part of a process for modifying or preparing the Methylphenidate Transdermal System patch before application.*

FDA Label Image

Figurec (Figurec)

An instructional diagram showing a transdermal patch with labeled components: adhesive with medicine, protective liner being peeled back, and the outside backing on the opposite side. The image illustrates the structure of the Methylphenidate Transdermal System patch.*

FDA Label Image

Figured (Figured)

An illustration of a transdermal patch labeled as 'outside backing,' showing the external side of the patch that adheres to the skin. The patch surface displays a repeating trademarked pattern or text.*

FDA Label Image

Figuree (Figuree)

An instructional line drawing showing two hands removing a transdermal patch from its packaging. The illustration demonstrates proper handling technique for the Methylphenidate Transdermal System patch prior to application.*

FDA Label Image

Figuref (Figuref)

An instructional illustration showing hands applying a Methylphenidate Transdermal System patch to the skin on the hip or torso area. The image demonstrates the positioning and adhesion process for the transdermal patch dosage form.*

FDA Label Image

Figureg (Figureg)

An instructional diagram showing hands peeling the backing off a transdermal patch, presumably the Methylphenidate Transdermal System, prior to application on the skin.*

FDA Label Image

Figureh (Figureh)

An instructional illustration showing a hand applying or positioning a transdermal patch on the skin of the upper arm or shoulder area, indicating proper placement or usage of a transdermal system.*

FDA Label Image

Padagis (Padagis)

FDA Label Image

Patch-cross-section (Patch Cross Section)

An illustration diagram of the Methylphenidate Transdermal System patch showing its layers, including the outside backing, adhesive containing methylphenidate, and the protective liner which is removed prior to application. The diagram is labeled and noted as not to scale.*

FDA Label Image

Square (Square)

Methylphenidate Transdermal System patch packaging with the strength of 55 mg/mg visible. The label indicates it is a transdermal patch containing the active ingredient methylphenidate, manufactured by Padagis US LLC. The packaging shows a single patch container with regulatory and usage information printed on it.*

FDA Label Image

Structure (Structure)

Chemical structure of methylphenidate, the active ingredient in Methylphenidate Transdermal System patches. The diagram shows the molecular arrangement including a piperidine ring, phenyl group, and ester functional group.*

FDA Label Image

Triangle (Triangle)

Methylphenidate Transdermal System patch packaging showing a strength of 41.3 mg/mg. The product is a prescription transdermal patch containing methylphenidate, manufactured by PADAGIS US LLC. The image depicts the front of the packaging with brand and generic names prominently displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.